|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Net earned premium | |||||
| Commission income, net | |||||
| Service and fee income | |||||
| Net investment income | |||||
| Total revenue, net | |||||
| Expenses: | |||||
| Losses and loss adjustment expenses | |||||
| Insurance related expenses | |||||
| Technology and development expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Impairment and restructuring charges | |||||
| Gain on sale of business | |||||
| Other income, net | |||||
| Interest and other (income) expense, net | |||||
| Total expenses | |||||
| Income (loss) before income taxes | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Net income attributable to noncontrolling interests, net of tax | |||||
| Net income (loss) attributable to Hippo | |||||
| Other comprehensive income (loss): | |||||
| Change in net unrealized gain on investments, net of tax | |||||
| Comprehensive income (loss) attributable to Hippo | |||||
| Per share data: | |||||
| Net loss attributable to Hippo - basic | |||||
| Net income (loss) per share attributable to Hippo - basic (in dollars per share) | |||||
| Net income (loss) per share attributable to Hippo - diluted (in dollars per share) | |||||
| Weighted average shares common shares outstanding - basic (in shares) | |||||
| Weighted average shares common shares outstanding - diluted (in shares) | |||||
Loading...